Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

HEOR and open access: COO Richard White contributes expertise to ISPOR article

Richard White, COO of Oxford PharmaGenesis, provides his expert insights on health economics and outcomes research (HEOR) publications and open access in a new article from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading global professional society for HEOR.

Continue reading
ISMPP US

Virtual 17th Annual Meeting of ISMPP

Share this page Overview Day 1 report Day 2 report Day 3 report Oxford PharmaGenesis at the Virtual 17th Annual Meeting of ISMPP Company overview video ISMPP is a fantastic opportunity to share best practice and connect with people who share our vision for what medical publications and communications can achieve. Chris Winchester, CEO Presentations…

Continue reading

Insights from the AMIA 2021 Virtual Informatics Summit

Last week marked the fourth Informatics Summit from the American Medical Informatics Association (AMIA). The meeting provided a fantastic opportunity for members of our Informatics and Data Science practice to stay up to date with the latest developments in the fields of artificial intelligence (AI), natural language processing and machine learning in the context of…

Continue reading

Oxford PharmaGenesis and the US Friends of the National Library of Medicine: building global networks together

The Friends of the US National Library of Medicine has elected Chris Winchester, CEO of Oxford PharmaGenesis, to its Board of Directors in recognition of the growing collaboration between the two organizations. The move bodes well for the disclosure and dissemination of medical evidence from the pharmaceutical industry and beyond.

Continue reading

Fourth year in the 'Pharma Fast 50' for Oxford PharmaGenesis

For the fourth year in a row, Oxford PharmaGenesis has been listed in the Alantra Pharma Fast 50 as one of the UK’s fastest-growing, privately owned pharmaceutical businesses.

Continue reading

Reporting from the Women in Data Science Conference

Today I’m attending the online Women in Data Science Worldwide Conference, along with tens of thousands of professionals, speakers, ambassadors and thought leaders reports Hollie Rawlings (Data Analyst – Informatics and Data Science).

Continue reading